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ABSTRACT: Low intrinsic toxicity, high solubility, and
stability are important and necessary features of gold
nanoparticles to be used in the biomedical ﬁeld. In this
context, charged nanoparticles proved to be very versatile, and
among them charged mixed-monolayer gold nanoparticles,
displaying monolayers with well-deﬁned morphologies,
represent a paradigm. By using mixtures of hydrogenated
and ﬂuorinated thiols, the formation of monolayer domains
may be brought to an extreme because of the immiscibility of
ﬂuorinated and hydrogenated chains. Following this rationale,
mixed monolayer gold nanoparticles featuring ammonium, sulfonate, or carboxylic groups on their surface were prepared by
using amphiphilic hydrogenated thiols and 1H,1H,2H,2H-perﬂuoro-alkanethiols. The toxicity of these systems was assessed in
HeLa cells and was found to be, in general, low even for the cationic nanoparticles which usually show a high cytotoxicity and is
comparable to that of homoligand gold nanoparticles displaying amphiphiliccharge neutralhydrogenated or ﬂuorinated
thiolates in their monolayer. These properties make the mixed ligand monolayer gold nanoparticles an interesting new candidate
for medical application.
■ INTRODUCTION
The unique lipophobic and hydrophobic nature of ﬂuorocom-
pounds represents a tremendous, but so far little exploited,
opportunity in the design of self-assembled materials. Indeed,
the use of ﬂuorinated (F-) subunits often yields species with
very diﬀerent structures and properties with respect to
hydrogenated (H-) analogues, oﬀering a simple way to expand
the diversity of systems for applications in the biomedical ﬁeld.
In this context, the extreme hydrophobicity of ﬂuorocom-
pounds may enable mechanisms of interaction with biologically
relevant structures, such as cell membranes, that are diﬀerent
from those operative for hydrogenated systems. In addition,
their stability, due to the strength of the C−F bonds, and low
toxicity may also allow developing safe devices with extended
lifetimes in vivo. Several examples highlight the remarkable
properties of nanosized ﬂuorinated systems that hold promise
to improve the eﬃcacy of nanomedicine. For instance,
decoration of gold nanoparticles (AuNPs) with short
perﬂuoroether moieties1 allowed their spontaneous self-
assemblytriggered by ﬂuorophilic interactionsinto hollow
superstructures2 in the absence of external templates. A similar
behavior was never reported for nanoparticles (NPs) bearing
solely polyether units in their outermost layer. These NPs
vesicles could be loaded with the ﬂuorescent dye rhodamine or
with the anticancer drug doxorubicin; this payload could then
be released by laser irradiation at 532 nm,3 presenting potential
as drug delivery systems based on AuNPs.4,5 Soft NPs made of
peptide nucleic acid (PNA) conjugated to perﬂuoroundecanoyl
chains display a 3-fold higher cellular uptake by HeLa cells with
respect to undecanoyl PNA.6 Soft NPs obtained by complex-
ation of polyampholites with perﬂuorododecanoic acid were
found to hinder the formation of amyloid ﬁbrils, while
hydrogenated analogues were not eﬀective.7,8 Furthermore, in
a thermodynamic analysis of water-soluble ﬂuorinated AuNPs
as putative drug delivery systems, we found that nanoparticles
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displaying ﬂuorinated ligands on their surface interact with
drug-like guests with higher aﬃnity than hydrogenated NPs of
similar structure.9 Fluorinated soft NPs have been, indeed,
proposed as drug delivery systems for doxorubicin.10,11 An
additional feature of ﬂuorinated materials, including AuNPs, is
that they may be easily engineered into contrast agents for 19F
magnetic resonance imaging,12,13 and by combining this
application with drug delivery, novel theranostic platforms
may become available.11 As far as monolayer protected AuNPs
are concerned, the immiscibility of F- and H-thiolate ligands,
arising from the lipophobicity of ﬂuorocompounds, favors their
self-sorting, with formation of domains, on the NPs sur-
face.14−16 This ﬁnding is in keeping with what was observed in
many examples of self-assembled systems comprising mixtures
of hydrogenated and ﬂuorinated components. For example,
formation of phase segregated domains was indeed observed in
the case of liposomes17 even when mixtures containing a mere
5% of ﬂuorinated amphiphiles were used. The same behavior
was also observed by AFM in a supported lipid bilayer of 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine and of a semiﬂuori-
nated analogue18 or in mixtures of arachidic and partially
ﬂuorinated carboxylic acids.19 On the other hand, studies on
mixed hydrogenated/ﬂuorinated self-assembled monolayers
(SAMs) on ﬂat surfaces are suggestive of less facile phase
segregation. In particular, the adsorption on Au(111) of mixed
disulﬁdes featuring a hydrogenated chain and a ﬂuorinated
chain of diﬀerent lengthsin a single disulﬁde molecule
results in the formation of SAMs with no evidence of phase
segregation.20,21 Occurrence of phase segregation was not
observed even after thermal annealing.22 Interestingly, coad-
sorption of a mixture of H- and F-thiols of the same length
produces SAMs that are indistinguishable from the SAMs
obtained by using the corresponding mixed disulﬁde.20 Instead,
adsorption of blends of dissimilar H- and F-thiols results in the
formation of small islands of the ﬂuorinated ligands.23
The self-sorting of hydrogenated and ﬂuorinated thiolates on
curved surfaces may be the basis for the preparation of
spontaneously patterned monolayers and provides a further
approach to control the morphology of mixed monolayers in
addition to those unraveled by the experimental and theoretical
analyses of Stellacci24,25 and Glotzer.26,27 In the context of
nanoparticles−cell interaction, aside from the surface
charge28,29 and functionalization,30,31 the morphology of the
coating monolayer is pivotal in determining the eﬃciency and
the mechanism of the internalization process;32−34 the latter
also being responsible for the toxicity of the NPs.35 This body
of evidence comes from thorough analyses of mixed monolayer
hydrogenated charged NPs of well-deﬁned morphologies,32
while the eﬀect of including F-ligands in the monolayer of these
charged systems is, at present, completely unexplored. No
information is also available on their toxicity in comparison to
similar charged hydrogenated NPs. To start ﬁlling this gap, we
then embarked in the synthesis of charged H-/F-mixed-
monolayer AuNPs by using blends of thiols in which one of
the components is a charged amphiphilic H-thiol while the F-
component is selected among the readily available
1H,1H,2H,2H-perﬂuoro-alkanethiols. In particular, in order to
favor the solubility in aqueous media the F-thiol length has to
be shorter than that of H-thiols but presenting at least six F-
methylene groups in order to exploit the lipophobicity
properties for the monolayer organization.15 These NPs
systems display good solubility in polar media, including
water. Their toxicity and internalization pathway were
preliminarily assessed on HeLa cells.
■ RESULTS AND DISCUSSION
For this study we prepared a series of H-/F-mixed monolayer
AuNPs with diﬀerent surface charges by using a mixture of
ligands as reported in Figure 1A. The sodium salts of the 11-
mercaptoundecansulfonic acid (HMUS) and 12-mercaptodo-
decanesulfonic acid (HMDDS) were used to provide NPs with
permanent negative charges. The 12-mercaptododecanoic acid
(HMDA) was used to provide the NPs with ionizable groups
on the surface while 12-mercapto-N,N,N-trimethyl-1-dodeca-
naminium chloride (HTMDA) was designed in order to obtain
NPs featuring permanent positive charges. These thiols were
Figure 1. Thiols used in the preparation of charged H-/F-mixed-monolayer NPs, panel A; thiols used for the preparation of charge neutral
homoligand AuNPs, panel B; and for NPs labeling, panel C.
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used in combination with 1H,1H,2H,2H-perﬂuoro-1-decane-
thiol (HF8) or 1H,1H,2H,2H-perﬂuoro-1-octanethiol (HF6) as
the ﬂuorinated components. The uptake by HeLa cells and the
cytotoxicity of these charged H-/F-mixed monolayer AuNPs
were compared to those of charge neutral NPs obtained by
using the thiols N-1-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-8-
sulfanyloctanamide (HC8TEG) and 2,2,3,3,4,4,5,5,6,6,7,7,8,8,
9,9-hexadecaﬂuoro-10-(methoxy-PEG550)decan-1-thiol
(HF8PEG), Figure 1B. The synthesis of the thiols HMDDS,
HMDA, and HTMDA is reported in the Supporting
Information (SI).
Nanoparticle Synthesis and Characterization. The
development of anionic H-/F-mixed monolayer NPs was
attempted at ﬁrst by using the hydrophilic thiols HMUS or
HMDDS blended to the highly hydrophobic thiol HF8 in a 2:1
molar ratio while the gold to thiol ratio was set to 1:1; the
preparations were achieved by direct synthesis following the
procedure reported by Stellacci and co-workers.36 The obtained
nanoparticles NP-MUS/F837 and NP-MDDS/F8 were essen-
tially insoluble in water. In seeking an improvement of the
system solubility, the F-ligand in the blend was replaced by the
shorter thiol HF6 and this was used in combination with
HMDDS, in order to ensure a better masking of the ﬂuorinated
thiolate, and/or of the ﬂuorinated domains, from the solvent.
The initial gold to thiols ratio was set to 2:1, in keeping with
the previous cases, while the HMDDS:HF6 ratio was set to
2:1.3 and the reducing agent was added dropwise over 15 min.
The nanoparticles NP-MDDS/F6-a thus obtained displayed an
average core diameter of 3.3 ± 0.5 nm, while, interestingly, the
molar ratio between the MDDS and F6 thiolates in the
monolayer was close to 5:1, very diﬀerent from the initial
HMDDS:HF6 ratio (Table 1), indicating that the introduction
of thiolate F6 in the monolayer of nanoparticles NP-MDDS/
F6-a is a disfavored process.38,39
In contrast to NP-MUS/F8 and NP-MDDS/F8, nano-
particles NP-MDDS/F6-a were nicely soluble in water. In order
to explore these types of NPs in more detail, diﬀerent values of
the HMDDS/HF6 ratios were tested. Nanoparticles NP-
MDDS/F6-b with a core diameter of 3.2 ± 0.7 nm and a
MDDS:F6 ﬁnal molar ratio of 2.5:1 could be obtained by using
an initial MDDS:F6 ratio of 1.3:1; hence, also in this case the
introduction of the F6 thiolate in the monolayer of nano-
particles NP-MDDS/F6-b is disfavored. The nanoparticles NP-
MDDS/F6-c with an average gold core diameter of 3.4 ± 0.7
nm and a mixed monolayer with a MDDS:F6 molar ratio of
1.5:1 were obtained by using an initial HMDDS:HF6 ratio of
1:0.9. With increasing amounts of F-ligand in the blend used for
the synthesis up to a HMDDS:HF6 ratio of 1:2, the NPs were
only soluble in ﬂuorinated solvents such as triﬂuorotoluene.
The preparation of the H-/F-mixed monolayer nanoparticles
NP-MDA/F6-a, NP-MDA/F6-b, and NP-MDA/F6-c, featuring
carboxylic groups on the surface was achieved by using blends
of the ligands HMDA and HF6 of diﬀerent composition while
maintaining constant the gold to total thiol molar ratio. The
nanoparticles were obtained by direct synthesis using ethanol as
solvent and a dropwise addition of the reducing agent over 15
min. The relevant synthetic and characterization data are
reported in Table 1.
Also with HMDA as hydrophilic ligand, the molar fraction of
the F-ligand in the self-assembled monolayer on the gold
surface was lower than that used for the synthesis. All of these
systems display good solubility in alcohols but are sparingly
Table 1. Characterization Data for the Nanoparticles Used in This Study
sample initial Ha:F6 xFin ﬁnal H:F6
b xFfin diameter,
c nm nanoparticles compositiond
NP-MDDS/F6-a 1:0.65 0.40 5.0:1 0.17 3.3 ± 0.5 Au1150(MDDS)145(F6)29
NP-MDDS/F6-b 1:0.77 0.44 2.5:1 0.29 3.2 ± 0.7 Au1289(MDDS)150(F6)60
NP-MDDS/F6-c 1:0.90 0.47 1.5:1 0.40 3.4 ± 0.7 Au1415(MDDS)129(F6)87
NP-MDA/F6-a 1:0.65 0.4 5.0:1 0.17 3.0 ± 0.5 Au976(MDA)136(F6)28
NP-MDA/F6-b 1:0.77 0.44 2.9:1 0.26 2.5 ± 0.6 Au523(MDA)90(F6)30
NP-MDA/F6-c 1:1.30 0.57 1.5:1 0.40 2.5 ± 0.3 Au523(MDDS)72(F6)49
NP-TMDA/F6-a 1:0.65 0.40 5.0:1 0.17 3.9 ± 0.9 Au2406(TMDA)256(F6)51
NP-TMDA/F6-b 1:0.77 0.43 1.1:1 0.48 4.2 ± 0.7 Au2406(TMDA)131(F6)119
NP-TMDA/F6-c 1:1.30 0.57 1.3:1 0.43 4.0 ± 0.9 Au2406(TMDA)160(F6)124
aH stands for the hydrogenated ligand. bDetermined on decomposed NPs by 1H NMR spectra analysis. cMeasured by TEM. dAverage NPs
composition was calculated considering TEM and TGA data.
Figure 2. Panel A: synoptic view of the solubility properties of the H-/F-mixed monolayer NPs. Color code: red insoluble; green good solubility;
indigo low solubility. Panel B: relationship between the initial composition of the reaction mixture and the ﬁnal composition of the monolayer of the
NPs expressed as the molar fraction of the F-ligand.
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soluble in water. The average size of the gold core for the
nanoparticles NP-MDA/F6 is similar to those of NPs obtained
by using the MDDS/F6 blends (Table 1).
The preparation of H-/F-mixed monolayer NPs featuring a
cationic surface was accomplished by using positively charged
HTMDA in combination with HF6. As in the preceding
examples, the preparation of the NPs was carried out by direct
synthesis using a gold to thiols ratio of 3:2, while the HTMDA/
HF6 ratio used was set to 1:0.65 for NP-TMDA/F6-a, 1:0.77
for NP-TMDA/F6-b, and 1:1.3 for NP-TMDA/F6-c, and their
characterization data are reported in Table 1. Also in this case,
the introduction of the HF6 ligand in the monolayer of the NPs
was found to be disfavored nicely matching the trend observed
for the negatively charged and charge neutral nanoparticles NP-
MDDS/F6 and NP-MDA/F6, respectively. However, the size
of the NPs core is slightly larger (see Table 1) than that
obtained by using blends of thiols HMDDS/HF6 and HMDA/
F6; the standard deviation of the core size is also larger. All
nanoparticles NP-TMDA/F6 are soluble in methanol and
ethanol and slightly soluble in water or basic buﬀers.
The introduction of polar end groups in the H-thiolates of
nanoparticles NP-MDDS/F6, NP-MDA/F6, and NP-TMDA/
F6 allows for the ﬁrst time a solubility in water which was not
observed for mixed-ligand coated NPs featuring nonfunction-
alized ﬂuorinated thiolates.15,38
A synoptic view of the solubility properties of NP-MDDS/
F6-b, NP-MDA/F6-c, and NP-TMDA/F6-c is presented in
Figure 2A. The relation between the composition of the H- and
F-ligands used in the NPs synthesis and the composition of the
resulting mixed monolayer can be conveniently analyzed by
plotting the ﬁnal molar fraction of the F-component in the
monolayer against the molar fraction of the ﬂuorinated ligand
in the reaction mixture (Figure 2B). By using thiol HF8, the
ﬁnal monolayer composition closely matches the initial
composition of the reaction mixture, while for NPs
preparations where thiol HF6 was employed, the fraction of
ﬂuorinated thiolate was lower than its initial value. This is likely
due to the combination of the lower number of ﬂuorophilic
interactions established between F6 chains and their shorter
length with respect to F8 chains. A similar eﬀect was observed
in the preparation of several mixed monolayer NPs protected
by blends of unfunctionalized hydrogenated thiolates and
1H,1H,2H,2H-perﬂuoro-alkanethiolates.38
Given the appreciable solubility of the nanoparticles NP-
MDDS/F6 and NP-TMDA/F6 in aqueous media, these
systems were used for cell uptake and cytotoxicity studies.
For comparison purposes, homoligandcharge neutral
AuNPs NP-C8TEG and NP-F8PEG were prepared by using
the ligands HC8TEG and HF8PEG (Figure 1B), according to
procedures already reported by our group.40,41
Tagging of Gold Nanoparticles with Fluorescent
Labels. Nanoparticles NP-MDDS/F6-b, NP-TMDA/F6-c,
NP-C8TEG, and NP-F8PEG were labeled with a ﬂuorescent
ligand in order to monitor the internalization process by
confocal ﬂuorescence microscopy and cytoﬂuorimetric analyses.
For labeling we used the Bodipy functionalized thiol HBodipy13
(Figure 1C), obtaining the nanoparticles NP-C8TEG/Bodipy,
NP-F8PEG/Bodipy, NP-MDDS/F6/Bodipy, and NP-TMDA/
F6/Bodipy (Table 2). The ﬂuorescent units were introduced in
the monolayer of the NPs by place exchange, the NPs were
dissolved in water or methanol, and the appropriate amount of
the HBodipy was added as a 1.95 mM solution in a water/DMF
4:1 mixture. The place exchange reaction was performed for 3
days at 28 °C. The degree of substitution was established by
decomposing the NPs and assessing the amount of dye in
solution by means of UV−vis spectroscopy and the resulting
compositions are reported in Table 2.
For all NPs the amount of ﬂuorescent dye introduced in the
ligand shell was kept lower than 10 units per nanoparticle to
avoid increasing the hydrophobicity of the NPs’ surface and, in
general, modifying the features of the monolayer.
Nanoparticle Interaction with HeLa Cells. The uptake of
charged H-/F-mixed monolayer coated nanoparticles NP-
MDDS/F6/Bodipy and NP-TMDA/F6/Bodipy by HeLa cells
was assessed by FACS analysis and ﬂuorescence confocal
microscopy imaging and compared to the uptake of the charge
neutral homoligand nanoparticles NP-C8TEG/Bodipy and NP-
F8PEG/Bodipy. Prior to study the interaction with HeLa cells,
the presence of free dye or free dye-labeled thiol HBodipy in
the NPs preparations was tested by the red blood cells (RBCs)
assay42 and no free dye could be detected (see Figure S22 and
Figure S23). For the internalization studies the HeLa cells were
plated at 3 × 105 cells/mL in complete medium (with serum)
and allowed to grow overnight. The cells were incubated with
Bodipy labeled NPs at the concentrations of 0.05, 0.1, and 0.2
mg/mL for 3.5 h at 37 °C and imaged live by confocal laser
scanning microscopy (CLSM). Cellular internalization of the
Bodipy labeled NPs is shown by red ﬂuorescence; the nucleus
(in blue) was stained with Hoechst 33342. For all samples,
cellular uptake is clear from confocal images with intense
ﬂuorescence signal in the cytosol and absence in the nucleus.
At 37 °C, both the negatively and positively charged
nanoparticles NP-MDDS/F6/Bodipy and NP-TMDA/F6/
Bodipy were internalized (Figure 3A,B), with a higher uptake
in the case of the positively charged NPs. At 4 °C, a
temperature at which the endocytic and pinocytic uptake
pathways are inhibited, no ﬂuorescence could be observed in
the cytoplasm of HeLa cells treated with NP-MDDS/F6/
Bodipy (Figure 3C), while in the case of NP-TMDA/F6/
Bodipy, the cell cytoplasm displayed a signiﬁcant red
ﬂuorescence (Figure 3D). This is clear indication that the
negatively charged particles are mainly internalized by an active
energy dependent pathway while the positive particles are able
to enter through the membrane into the cytosol of the cell.
A similar eﬀect has been reported for other cationic NPs,43,44
and in silico analyses of the process45,46 explain it by NP entry
through nanosized holes in the plasma membrane usually
connected to signiﬁcant cytotoxicity.
Accordingly, the cytotoxicity of the tested nanoparticles was
determined by FACS analyses (Figure 4). For this, HeLa cells
were incubated with NPs for 3.5 h at the concentrations of 0.05,
0.1, and 0.2 mg/mL. Then the nonmembrane permeable
ﬂuorescent DNA-binding propidium iodide (PI) was used to
determine cell membrane integrity.
Table 2. Characterization Data of the Bodipy Labeled
Nanoparticles
sample
BODIPY units per
NP nanoparticle composition
NP-F8PEG/Bodipy 6 Au976(F8PEG)114(BODIPY)6
NP-C8TEG/Bodipy 2 Au760(C8TEG)168(BODIPY)2
NP-MDDS/F6/
Bodipy
6 Au1289(MDDS/
F6)204(BODIPY)6
NP-TMDA/F6/
Bodipy
5 Au2406(TMDA/
F6)279(BODIPY)5
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We observed that the negatively charged NP-MDDS/F6/
Bodipy showed limited cytotoxicity to moderate toxicity in a
concentration dependent manner with 38% of the cell
population labeled with both NPs and PI indicating disruption
of the cell membrane at a concentration of 0.2 mg/mL (Figure
S24). In an assessment of NPs toxicity toward mammalian cells,
Rotello and co-workers47 reported that anionic NPs, featuring,
for instance, carboxylate groups on their surface, are less toxic
than cationic NPs, with the anionic displaying LC50 values
about 1 order of magnitude higher than the cationic.
Surprisingly, we found that the positively charged NP-
TMDA/F6/Bodipy showed at maximum 7% of PI positive
cells after exposure to the highest tested NPs concentration of
0.2 mg/mL (Figure S25). These percentages are comparable to
those measured for untreated control cells. The limited toxicity
of NP-TMDA/F6/Bodipy may imply that these cationic
nanoparticles, at the concentrations tested, do not exert
extensive damage to the plasma membrane upon internal-
ization. For similar cationic hydrogenated nanoparticles,
Rotello and co-workers reported a LC50 of about 1 μM; in
the case of NP-TMDA/F6/Bodipy the highest concentration
tested for which we could not observe cytotoxic eﬀects was 0.2
mg/mL, corresponding to 0.35 μM, that is signiﬁcantly lower
than the LC50 value reported. It is thus intriguing that the
anionic NP-MDDS/F6/Bodipy, instead, exert a signiﬁcantly
higher toxic eﬀect than NP-TMDA/F6/Bodipy when tested at
similar concentration levels. However, a recent thorough
investigation of nanoparticle toxicities, by Stellacci and
Pompa,35 on six cell lines, including HeLa cells, displays that
nanoparticles presenting sulfonate groups on their surface and
whose monolayer featured stripe-like domains remain essen-
tially noncytotoxic at the same concentration at which
nonstructured anionic nanoparticles exert a cytotoxic eﬀect. It
is not unlikely that in the case of NP-MDDS/F6/Bodipy the
toxic eﬀects observed are due to the organization of the
monolayer. This hypothesis is also corroborated by the absence
of internalization at 4 °C for nanoparticles NP-MDDS/F6/
Bodipy which might be expected if these nanoparticles present
a stripe-like organization of the monolayer in analogy to similar
mixed monolayer nanoparticles.24
The charge neutral nanoparticles NP-C8TEG/Bodipy and
NP-F8PEG/Bodipy were also eﬃciently internalized at 37 °C,
as evidenced by the strong intensity of the red ﬂuorescence in
Figure 5A and Figure 6A, respectively. By performing the same
experiments at 4 °C, cellular uptake of NP-C8TEG/Bodipy or
NP-F8PEG/Bodipy (Figure 5B and Figure 6B, respectively)
was inhibited.
Cytoﬂuorimetric analyses for NP-C8TEG/Bodipy showed
no signiﬁcant cytotoxicity; for all concentrations tested, more
than 90% of the cells were viable after incubation with 0.05 and
0.1 mg/mL of the NPs for 3.5 h (Figure 5C and Figure 5D,
respectively).
At the higher concentration of 0.2 mg/mL (Figure S26), the
percentage of dead cells remains fairly constant and close to
that measured in control experiments with untreated cells.
Nanoparticles NP-F8PEG/Bodipy gave similar results up to
the concentration of 0.05 and 0.1 mg/mL (Figure 6C,D,
respectively), while at the higher concentration tested, some
cytotoxicity could be observed. Indeed, after exposure to 0.2
mg/mL of NP-F8PEG/Bodipy the percentage of PI stained
cells containing NPs was 16% (Figure S27). These data are in
line with the toxicity of other homoligand PEG decorated
ﬂuorinated NPs.13
■ CONCLUSIONS
In this proof-of-principle study the preparation of a series of
mixed H-/F-mixed monolayer AuNPs featuring cationic and
anionic surfaces was achieved by direct synthesis using blends
of simple hydrogenated thiols with charged end groups and
commercially available 1H,1H,2H,2H-perﬂuoro-alkanethiols.
Figure 3. Confocal ﬂuorescence micrographs merged with light
microscopy images of HeLa cells incubated for 3.5 h at 37 °C at a
concentration of 0.1 mg/mL with NP-MDDS/F6/Bodipy (panel A),
scale bar: 20 μm. Panel B: NP-TMDA/F6/Bodipy, scale bar: 20 μm.
Confocal ﬂuorescence micrographs merged with light microscopy
images of HeLa cells incubated for 3.5 h at 4 °C at a concentration of
0.1 mg/mL with NP-MDDS/F6/Bodipy (panel C), scale bar: 20 μm.
Panel D: NP-TMDA/F6/Bodipy, scale bar: 20 μm. The nucleus in all
experiments was stained by Hoechst 33342 (blue).
Figure 4. FACS analysis of HeLa cells incubated for 3.5 h at 37 °C
with NP-MDDS/F6/Bodipy at a concentration of 0.05 mg/mL (panel
A) and 0.1 mg/mL (panel B), or with NP-TMDA/F6/Bodipy at a
concentration of 0.05 mg/mL (panel C) and 0.1 mg/mL (panel D).
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The exploration of the ligand structure highlights that the
length of the ﬂuorinated thiol or, most likely, the diﬀerence in
length between the hydrogenated and ﬂuorinated ligands is a
critical parameter to be considered for obtaining NPs with
acceptable solubility properties. The ﬂuorinated thiol has to be
short enough, compared to the hydrogenated ligand, to form
ﬂuorinated domains that are suﬃciently small to be masked
from the solvent. In the present study we explored this aspect
and found that the thiol HF8 is too long, producing NPs that
are poorly soluble; on the contrary, the use of the two CF2 units
shorter HF6 gave NPs with improved solubility. By this
approach we achieved a tremendous broadening of the solvent
spectrum in which H-/F-mixed monolayer NPs can be studied,
including acetone, alcohols, and, most notably, water. At
variance with previous examples, the systems presented here
carry speciﬁc charged moieties paving the way to applications
and studies thus far out of reach. The solubility in aqueous
media of anionic NP-MDDS/F6 and cationic NP-TMDA/F6
nanoparticles, though not yet optimal, allowed us to perform
some preliminary uptake and cytotoxicity studies toward HeLa
cells. Both charged nanoparticle systems were readily
internalized, but in uptake studies performed at 4 °C, only
NP-TMDA/F6 were found to enter the cells, suggesting that
diﬀerent internalization pathways are available to the diﬀerent
NPs. Nanoparticles NP-TMDA/F6 displayed only a limited
toxicity and were well tolerated by the cells up to a
concentration of 0.2 mg/mL indicating that, despite the
cationic nature of this system, at this concentration there is
little perturbation of the cell membrane. Instead, nanoparticles
NP-MDDS/F6 displayed some cytotoxicity when tested at the
same concentration. The charge neutral homoligand nano-
particles NP-C8TEG and NP-F8PEG were also tested for their
cytotoxicity, and while the former were found to be nontoxic at
all the concentration tested, the latter displayed some
cytotoxicity when used at a concentration of 0.2 mg/mL.
Overall, the cationic nanoparticles NP-TMDA/F6 display
toxicity similar to that of the charge neutral NPs. Given the
well-established tendency of ﬂuorinated thiolates to self-sort on
the surface of AuNPs and the now available synthetic strategies
to charged H-/F-mixed monolayer AuNPs we are conﬁdent
that these systems, after further structural reﬁnement, will
signiﬁcantly widen the span of NP systems with anisotropic
monolayers to probe the interactions of nanosized matter with
the biological environment.
■ EXPERIMENTAL PROCEDURES
Synthesis of NP-MDDS/F6-a. A 250 mL three-neck
round-bottom ﬂask was charged with 88.8 mg (2.29 × 10−4
mol, 1 equiv) of HAuCl4·3H2O dissolved in 50 mL of
deoxygenated ethanol and 1.52 × 10−4 mol (0.66 equiv) of the
thiol mixture (HF6:HMDDS = 0.65:1). Then a 0.11 M solution
of NaBH4 in deoxygenated ethanol (2.59 × 10
−3 mol, 11.3
equiv) was added dropwise over 15 min. The solution becomes
brown-reddish and some precipitation of NPs was observed.
The mixture was stirred for 3 h at room temperature, and
afterward, the reaction vessel was kept at 4 °C overnight; the
precipitated NPs were collected and the solvent was discarded.
The NPs were washed with ethanol, methanol, and acetone and
dried under vacuum. To completely remove unbound ligands,
particles were dialyzed against 1 L of Milli-Q water for a total
time span of 72 h; the system was recharged with fresh water
every 8 h. The NP solution was collected and the solvent was
removed under vacuum at a temperature lower than 45 °C
obtaining the NPs as a red solid. The ﬁnal ratio MDDS:F6 was
5:1. Solubility properties: Good solubility in water; not soluble
in ethanol, methanol, and acetone. UV−vis (water) λmax (nm):
Weak surface plasmon band at 508 nm. 1H NMR (500 MHz,
D2O): δ = 0.9−1.60 (br, CH2), 1.77 (br, CH2CH2SH and
Figure 5. Merged light microscopy and confocal ﬂuorescence images
of HeLa cells incubated at a concentration of 0.1 mg/mL for 3.5 h with
NP-C8TEG/Bodipy at 37 °C (A) NP-C8TEG/Bodipy or at 4 °C (B);
scale bars: 20 μm. FACS analysis of HeLa cells incubated for 3.5 h with
NP-C8TEG/Bodipy at a concentration of 0.05 mg/mL (C) or 0.1
mg/mL (D).
Figure 6. Merged light microscopy and confocal ﬂuorescence images
of HeLa cells incubated at a concentration of 0.1 mg/mL for 3.5 h with
NP-F8PEG/Bodipy at 37 °C (A) or at 4 °C (B); scale bars: 20 μm.
FACS analysis of HeLa cells incubated for 3.5 h with NP-F8PEG/
Bodipy at a concentration of 0.05 mg/mL (C) or 0.1 mg/mL (D).
Bioconjugate Chemistry Article
DOI: 10.1021/acs.bioconjchem.6b00585
Bioconjugate Chem. 2017, 28, 43−52
48
CH2CH2SO3Na), 2.88 (br, CH2SO3Na). TEM: Xm = 3.1 nm; σ
= 0.8 nm; n = 134. TG Analysis: 19.5%. Average composition:
Au1150(MDDS)145(F6)29.
Synthesis of NP-MDDS/F6-b. A 250 mL round-bottom
ﬂask was charged with 100 mg (2.54 × 10−4 mol, 1 equiv) of
HAuCl4·3H2O dissolved in 56 mL of deoxygenated ethanol and
1.69 × 10−4 mol (0.66 equiv) of the thiols mixture
(HF6:HMDDS = 0.77:1). Then, a 0.11 M solution of NaBH4
in deoxygenated ethanol (2.87 × 10−3 mol, 11.3 equiv) was
added dropwise over 17 min. The solution becomes brown-
reddish and some precipitation of NPs was observed. The
mixture was stirred for 3 h at room temperature and afterward
the reaction vessel was kept at 4 °C overnight; the precipitated
NPs were collected, and the solvent was discarded. The NPs
were washed with ethanol, methanol, and acetone and dried
under vacuum. The NPs were dialyzed against 1 L of Milli-Q
water for 72 h, recharging the system with fresh water every 8 h.
The NP solution was collected and the solvent was removed
under reduced pressure working at temperature below 45 °C.
The residue was washed several times with hot ethanol to
remove unbound thiols. The ﬁnal ratio MDDS:F6 was 2.5:1.
Solubility properties: Good solubility in water; not soluble in
ethanol, methanol, and acetone. UV−vis (water) λmax (nm):
Weak surface plasmon band at 508 nm. 1H NMR (500 MHz,
D2O): δ = 0.9−1.60 (br, CH2), 1.77 (br, CH2CH2SH and
CH2CH2SO3Na), 2.88 (br, CH2SO3Na). TEM: Xm = 3.2 nm; σ
= 0.7 nm; n = 253. TG Analysis: 21%. Average composition:
Au1289(MDDS)150(F6)60.
Synthesis of NP-MDDS/F6-c. A 250 mL round-bottom
ﬂask was charged with 97.3 mg (2.47 × 10−4 mol, 1 equiv) of
HAuCl4·3H2O dissolved in 55 mL of deoxygenated ethanol and
1.65 × 10−4 mol (0.66 equiv) of the thiol mixture
(HF6:HMDDS = 1:1.1). Then, a 0.11 M solution of NaBH4
in deoxygenated ethanol (2.80 × 10−3 mol, 11.3 equiv) was
added dropwise over 12 min. The solution becomes brown-
reddish observing some precipitation of NPs. The mixture was
stirred for 3 h at room temperature and afterward the reaction
vessel was then kept at 4 °C overnight; the precipitated NPs
were collected and the solvent was discarded. The NPs were
washed with ethanol, methanol, and acetone and dried under
vacuum. The NPs were taken up with water and dialyzed
against Milli-Q water for 72 h recharging the system with fresh
water every 8 h. The NPs solution was collected and the solvent
was removed under reduced pressure working at a temperature
lower than 45 °C. To completely remove unbound ligands, NPs
were washed several times with hot ethanol. The ﬁnal ratio
MDDS:F6 was 1.5:1. Solubility properties: Good solubility in
water; not soluble in ethanol, methanol, and acetone. UV−vis
(water) λmax (nm): Weak surface plasmon band at 510 nm.
1H
NMR (500 MHz, D2O): δ = 0.9−1.60 (br, CH2), 1.77 (br,
CH2CH2SH and CH2CH2SO3Na), 2.88 (br, CH2SO3Na).
TEM: Xm = 3.4 nm; σ = 0.7 nm; n = 209. TG Analysis: 16%.
Average composition: Au1415(MDDS)129(F6)87.
Synthesis of NP-MDA/F6-a. A 250 mL round-bottom ﬂask
was charged with 80 mg (0.20 × 10−3 mol, 1 equiv) of HAuCl4·
3H2O dissolved in 44 mL of deoxygenated ethanol and 0.14 ×
10−3 mol (0.66 equiv) of the thiol mixture (HF6:HMDA =
0.65:1). Then, a 0.11 M solution of NaBH4 in deoxygenated
ethanol (2.3 × 10−3 mol, 11.3 equiv) was added dropwise over
15 min. The mixture was stirred for 3 h and the reaction vessel
was then kept at 4 °C overnight; the precipitated NPs were
collected and the solvent was discarded. The precipitated NPs
were washed with ethanol and acetone and dried under
vacuum. The NPs were dialyzed against Milli-Q water for 72 h
recharging the system with fresh water ca. every 8 h. The NP
solution was collected and the solvent was removed under
vacuum working at temperature below 45 °C. The NPs were
further puriﬁed by size exclusion chromatography on Sephadex
LH-20 using methanol as eluent. The ﬁnal ratio MDA:F6 was
5:1. Solubility properties: Good solubility in ethanol, methanol,
and acetone. UV−vis (water) λmax (nm): Weak surface plasmon
band at 500 nm. 1H NMR (500 MHz, D2O): δ = 1.10−1.50
(br, CH2), 1.60 (br, CH2CH2SH and CH2CH2COOH), 2.85
(br, CH2COOH) ppm. TEM: Xm = 3.01 nm; σ = 0.52 nm; n =
234 . TG Ana ly s i s : 20%. Average compos i t ion :
Au976(MDA)136(F6)28.
Synthesis of NP-MDA/F6-b. A 250 mL round-bottom
ﬂask was charged with 99.3 mg (0.25 × 10−3 mol, 1 equiv) of
HAuCl4·3H2O dissolved in 56 mL of deoxygenated ethanol and
0.17 × 10−3 mol (0.67 equiv) of the thiols mixture
(HF6:HMDA = 0.76:1). Then, a 0.11 M solution of NaBH4
in deoxygenated ethanol (2.83 × 10−3 mol, 11.3 equiv) was
added dropwise over 15 min. The mixture was stirred for 3 h
and the reaction vessel was then kept at 4 °C overnight; the
precipitated NP were collected and the solvent was discarded.
The precipitated NPs were washed with ethanol (3 × 20 mL),
acetone (3 × 20 mL), and DCM (3 × 20 mL) and dried under
vacuum obtaining 43.4 mg of NPs. The ﬁnal ratio MDA:F6 was
2.9:1. Solubility properties: Low solubility in ethanol and
acetone; good solubility in methanol. UV−vis (methanol) λmax
(nm): Weak surface plasmon band at 523 nm. 1H NMR (500
MHz, CD3OD): δ = 1.10−1.50 (br, CH2), 1.60 (br,
CH2CH2SH and CH2CH2COOH), 2.19 (br, CH2COOH)
ppm. TEM: Xm = 2.45 nm; σ = 0.56 nm; n = 488. TG Analysis:
33%. Average composition: Au523(MDA)90(F6)30.
Synthesis of NP-MDA/F6-c. A three-neck round-bottom
ﬂask was charged with 81.8 mg (2.08 × 10−4 mol, 1 equiv) of
HAuCl4·3H2O dissolved in 45 mL of deoxygenated ethanol and
1.38 × 10−4 mol (0.66 equiv) of the thiol mixture
(HF6:HMDA = 1.3:1). Then, a 0.11 M solution of NaBH4 in
deoxygenated ethanol (2.35 × 10−3 mol, 11.3 equiv) was added
dropwise over 11 min. The mixture was stirred at room
temperature for 3 h and then the NPs were precipitated by
addition of hexane. The precipitate was repeatedly washed with
hexane and the crude material was further puriﬁed by gel
permeation chromatography on Sephadex LH-20 using
methanol as eluent. The puriﬁed NPs were obtained as a
brown-red solid. The ﬁnal ratio MDA:F6 was 1.5:1. Solubility
properties: Good solubility in ethanol, methanol, and acetone.
UV−vis (water) λmax (nm): Weak surface plasmon band at 508
nm. 1H NMR (500 MHz, CD3OD): δ = 0.9−1.50 (br, CH2),
1.60 (br, CH2CH2SH and CH2CH2COOH), 2.25 (br,
CH2COOH). TEM: Xm = 2.5 nm; σ = 0.3 nm; n = 204.
Average composition: Au523(MDA)72(F6)49.
Synthesis of NP-TMDA/F6-a. A 250 mL three-neck
round-bottom ﬂask was charged with 80 mg (2.03 × 10−4
mol, 1 equiv) of HAuCl4·3H2O dissolved in 44 mL of
deoxygenated ethanol and 1.35 × 10−4 mol (0.66 equiv) of the
thiol mixture (HF6:HTMDA = 0.65:1). Then, a 0.11 M
solution of NaBH4 in deoxygenated ethanol (2.3 × 10
−3 mol,
11.3 equiv) was added dropwise over 15 min. The solution
becomes brown, observing some precipitation of the NPs. The
mixture was stirred for 3 h and the reaction vessel was then
kept at 4 °C overnight; the precipitated NPs were collected and
the solvent was discarded. The crude material was repeatedly
washed with DCM to remove unbound ligands. The ﬁnal ratio
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TMDA:F6 is 5:1. Solubility properties: soluble in methanol,
ethanol; low solubility in water. UV−vis (water) λmax (nm):
surface plasmon band at 525 nm. 1H NMR (500 MHz,
CD3OD): δ = 3.33 (br, CH2N(CH3)3), 3.17 (br, N(CH3)3),
1.78 (br, CH2CH2N(CH3)3), 1.60−0.9 (br, CH2). TEM: Xm =
3.9 nm; σ = 0.9 nm; n = 583. TG Analysis: 19%. Average
composition: Au2406(TMDA)256(F6)51.
Synthesis of NP-TMDA/F6-b. A 250 mL three-neck
round-bottom ﬂask was charged with 101 mg (0.25 × 10−3
mol, 1 equiv) of HAuCl4·3H2O dissolved in 56 mL of
deoxygenated ethanol and 0.169 × 10−3 mol (0.68 equiv) of the
thiol mixture (HF6:HTMDA = 0.77:1). Then, a 0.11 M
solution of NaBH4 in deoxygenated ethanol (2.88 × 10
−3 mol,
11.3 equiv) was added dropwise over 20 min. The solution
became brown, observing some precipitation of the NPs; the
mixture was stirred for 3. The precipitated NPs were collected
and the solvent discarded. The crude material was washes with
acetone (3 × 20 mL), DCM (3 × 20 mL), and acetone (6 × 20
mL); the crude material was dissolved in a few milliliters of
methanol and the NPs were precipitated by adding hexane. The
precipitate was washed with DCM (2 × 20 mL), acetone (2 ×
20 mL), and DCM (2 × 5 mL) and dried obtaining 53.5 mg of
clean NPs as a reddish solid. The ﬁnal ratio TMDA:F6 was
1.1:1. Solubility properties: soluble in methanol, ethanol; low
solubility in water. UV−vis (water) λmax (nm): surface plasmon
band at 521 nm. 1H NMR (500 MHz, CD3OD): δ = 3.33 (br,
CH2N(CH3)3), 3.17 (br, N(CH3)3), 1.78 (br, CH2CH2N-
(CH3)3), 1.60−0.9 (br, CH2). TEM: Xm = 4.16 nm; σ = 0.7
nm; n = 339. TG Analysis: 15%. Average composition:
Au2406(TMDA)131(F6)119.
Synthesis of NP-TMDA/F6-c. A 250 mL three-neck round-
bottom ﬂask was charged with 98 mg (0.249 × 10−3 mol, 1
equiv) of HAuCl4·3H2O dissolved in 54 mL of deoxygenated
ethanol and 0.166 × 10−3 mol (0.66 equiv) of the thiol mixture
(HF6:HTMDA = 1.3:1). Then, a 0.11 M solution of NaBH4 in
deoxygenated ethanol (2.82 × 10−3 mol, 11.3 equiv) was added
dropwise over 15 min. The solution became brown, observing
some precipitation of the NPs; the mixture was stirred for 3 h
and afterward the reaction vessel was placed at 4 °C overnight.
The precipitated NPs were collected and the solvent discarded.
The crude material was washed with DCM obtaining 46 mg of
clean NPs as a reddish solid. The ﬁnal ratio TMDA:F6 was
1.3:1. Solubility properties: Soluble in methanol, ethanol; low
solubility in water. UV−vis (water) λmax (nm): surface plasmon
band at 525 nm. 1H NMR (500 MHz, CD3OD): δ = 3.33 (br,
CH2N(CH3)3), 3.17 (br, N(CH3)3), 1.78 (br, CH2CH2N-
(CH3)3), 1.60−0.9 (br, CH2). TEM: Xm = 4.0 nm; σ = 0.9 nm;
n = 362. TG Analysis: 16%. Average composition:
Au2406(TMDA)160(F6)124.
Preparation of NP-MDDS/F6/Bodipy. In a 25 mL round-
bottom ﬂask 11.4 mg of NP-MDDS/F6-b was dissolved by
using 5 mL of deoxygenated mQ water under an argon
atmosphere, and 150 μL of a 1.94 mM solution of HBodipy in
DMF/H2O 4/1 was added; the mixture was kept under stirring
at 25 °C for 4 days. To completely remove unbound ligands,
particles were dissolved in Milli-Q water and dialyzed against
millQ water for a total time of 72 h. The system was recharged
with fresh water every 8 h. The NPs solution was collected
from the dialysis tube and used as such.
Preparation of NP-TMDA/F6/Bodipy. In a 25 mL round-
bottom ﬂask 10 mg of NP-TMDA/F6-c was dissolved by using
5 mL of deoxygenated mQ water under an argon atmosphere,
and 150 μL of a 1.94 mM solution of HBodipy in DMF/H2O
4/1 were added; the mixture was kept under stirring at 25 °C
for 4 days. The NPs were puriﬁed by dialysis against 1 L of
Milli-Q for a total time of 72 h recharging the system with fresh
water every 8 h. The NPs solution was used as such.
Preparation of NPs-C8TEG/Bodipy. In a 25 mL round-
bottom ﬂask 10 mg of NP-C8TEG was dissolved using 5 mL of
deoxygenated methanol under an argon atmosphere, and 150
μL of a 1.94 mM solution of HBodipy in DMF/H2O 4/1 was
added; the mixture was kept under stirring at 25 °C for 4 days.
The solvent was removed under reduced pressure at a
temperature below 45 °C. To completely remove unbound
ligands, the NPs were puriﬁed by size exclusion chromatog-
raphy by using Sephadex LH-20 and methanol as eluent.
Preparation of NP-F8PEG/Bodipy. In a 25 mL round-
bottom ﬂask 10 mg of NPs-F8PEG was dissolved using 5 mL of
deoxygenated methanol under an argon atmosphere, and 150
μL of a 1.94 mM solution of HBodipy in DMF/H2O 4/1 was
added; the mixture was kept under stirring at 25 °C for 4 days.
The solvent was removed under reduced pressure at a
temperature below 45 °C. The NPs were puriﬁed by size
exclusion chromatography by using Sephadex LH-20 and
methanol as eluent.
Cell Culture and Fluorescence Imaging. Human cervical
carcinoma cells (HeLa) were grown in a standard culture media
at 37 °C and in 95% air/5% CO2 atmosphere. Cells were
seeded in a μ-Slide 8-well ibidi plate (Martinsried, Germany) at
a density of 5 × 104 cells per well (1.0 cm2) and were allowed
to adhere overnight. Before cell incubation with nanoparticles,
the medium containing fetal bovine serum was replaced with
serum-free medium to avoid unspeciﬁc binding of the NPs to
serum proteins. Cells were then incubated with Bodipy labeled
NP for 3.5 h at 37 °C. After incubation the cells were washed 3
times with PBS. Nuclei were counterstained with Hoechst
33342 (Invitrogen, Oregon, USA), according to the manu-
facturer’s instructions. Cellular internalization of the ﬂuores-
cently labeled NP was visualized with an inverted confocal laser
scanning microscope (CLSM, Carl Zeiss LSM 510) equipped
with a 63×/1.3 oil DIC objective, using excitation lines at 405
(Hoechst 33342) and 633 nm (Bodipy (650/665 nm)). ImageJ
software was used for image analysis.
Cell ViabilityFACS Analysis. HeLa cell incubation with
Bodipy labeled NPs in a concentration range of 0.05−0.2 mg/
mL was performed as described above. After incubation, 5 ×
105 cells were collected by trypsination and washed with PBS
containing 1% BSA. The staining of nonviable cells was
performed with Propidium Iodide (50 μg/mL in PBS) for 5
min at room temperature. The samples were analyzed
immediately on a ﬂow cytometer (FACS Canto II, BD
Biosciences) with excitation at 488 nm for PI and an excitation
at 633 nm for Bodipy.
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